Although the LNX3-RAF1 fusion protein may undergo constitutive activation, following which it can ceaselessly activate downstream MAPK pathways, the detailed molecular mechanisms underlying tumor development should be addressed in future studies. Here, PDZRN3 is linked to neoplasm.